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Abstract 
Background: Esophageal cancer is often diagnosed in the last stages where 
the chance of patient’s survival is very low. The aim of this systematic review 
was presentation of valid estimation of survival in patients with esophageal 
cancer in different regions of Iran. 
Methods: A systematic review was carried out based on the reliable domestic 
medical databases including: SID, Magiran, Irandoc and Iranmedex as well as 
reliable foreign databases like PubMed and Scopus using “Cancer”, 
“Esophagus”, “survival” “Neoplasms” and “Longevity” as keywords. Then all 
the reviewed articles and dissertations which met the entry criteria were 
analyzed. The data were analyzed by using meta-analysis method (random 
model) and by means of STATA software application version 11.1. 
Results: In 18 studies the total numbers of 2932 people were analyzed. The 
one year survival rate in Iran is estimated at 47 percent (95% CI: 34-61) and 
the five year survival rate is estimated at 12% (95% CI: 8-16). The two, three 
and four year survival rates were 31% (95% CI: 18-44), 22% (95% CI: 13-31) 
and 21% (95% CI: 4-38), respectively. 
Conclusion: According to the findings one year survival rate for esophageal 
cancer in Iran is almost four times higher than its five year survival rate. 
Moreover the five year survival rate in Iran is less than many other countries. 
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Introduction 
Esophageal cancer is the sixth cause of death in 
the world, which kills about 386000 people each 
year [1]. Regarding diagnosis and outcome 
esophageal cancer is one of the most important 
malignant cancers [2]. Fatality rate of esophageal 
tumors among victims is high and reported about 
90%. The survival rate for these patients is very low 
and only 12% and 4% for female and male patients, 
respectively in Caspian region [3]. The highest 
number of outbreaks was reported in north parts of 
China (average of 100 to 180 Per 100,000 people). 
While in the USA this amount is 20 Per 100,000 
people [4]. Among 5800 reported cases in Iran, 
about 3,500 of them die each year [5]. Diari et al. in 
1975 in Tehran University reported that the northern 
region of Iran - including Ardebil, Gilan, 
Mazandaran, Golestan and North Khorasan 
provinces is highest Incidence region in Iran, In this 
regions Gilan province has the lowest Incidence and 
North Khorasan has the highest Incidence [6].  
Estimation of survival rate in patients with 
esophageal cancer can help improve the preventive 
and curative services and assess the effectiveness of 
new treatments [7]. Victim’s quality of life is very 
important and we should pay more attention to this 
matter [8]. 
Many studies have been conducted in the past 
two decades in relation to survival rate of 
esophageal cancer in Iran. This systematic review 
assesses all accessing electronic databases to 
determine valid estimation of survival rate among 
patients with esophageal cancer in different regions 
of Iran. 
Yarhusseini et al. 
Iranian Journal of Cancer Prevention 
62 
Materials and Methods 
Sources for the data 
The systematic review carried out about 
survival rate of esophageal cancer that required 
search all available sources and electronic databases 
related articles and dissertations as well as the meta-
analysis. These databases include the reliable 
domestic databases such as Iranmedex, Medlib, 
MagIran and SID as well as the foreign websites 
such as PubMed/Medline, ISI Web of Knowledge 
and Scopus. We queried the articles and 
dissertations using sensitive keywords including 
“cancer”, “esophagus”, “survival” “Neoplasms” and 
“longevity” and a combination of them. In order to 
prevent any bias, the search was carried out by two 
researchers separately. All articles and dissertations 
which evaluated the survival time and longevity of 
the esophageal cancer and published up to 2011 
entered into the first step of study without any kind 
of limitations. After preliminary review, review 
articles about esophageal cancer without any 
evaluations on the survival time and papers with 
insufficient data were omitted from the study. In 
second step we evaluated 340 articles on esophageal 
cancer among them 40 ones were repetition, 145 
ones irrelevant that omitted from study. Result from 
full text review 137 article exclude due to 
insufficient data. Finally 18 articles with proper 
quality were entered into the process of meta-
analysis (Chart 1 at the bottom of the text). 
 
Data Extraction 
Data extraction form was used to record the all 
required data in the study. This form included 
sample size, study region, gender, 1 year to 5 year 
survival rate, histology type, as well as affected area 
of esophagus. 
Statistics 
In every article the one to five year survival rate 
was considered as the probability of a two-term 
distribution and its variance was calculated using 
two-term distribution. Incongruity of the studies was 
determined using the Q-test and I2 measure. Due to 
the incongruity of the studies we used the random 
effect model for combining the results of them. The 
analysis in the sub-groups was carried out regarding 
the under-study region (North, Center, East and 
Tehran). The data were analyzed using STATA 
software application version 11.1. The significance 
level of the tests was considered 5%. 
 
Results 
Overall, 18 articles included according to 
inclusion criteria in the meta-analysis. Looking for 
sample sizes, 2932 patients enrolled study. 11 
articles (61%) were performed in the northern parts 
of Iran, 3 ones (16.6%) were carried out in central 
parts; one (5.5%) was conducted in the eastern parts 
and 3 ones (16.6%) were accomplished in Tehran 
province. Studies were published between 1 January 
1989 and 31 August 2010 (Table 1).  
According to results from Meta-analysis, the 
one-five year survival rate for esophageal cancer in 
this study were 47% (CI 95%: 34-61), 31% (CI 
95%: 18-44), 22% (CI 95%: 13-31), 21% (CI 95%: 
4-38) and 12% (CI 95%: 8-16), respectively (Table 
2). 
Geographical variation results on survival rate 
in our study indicated the one year survival rate in 
northern region, with eight articles enrolled in meta-
analysis was 45% (CI 95%: 28-62), in the northwest 
region, with one study was 68% (CI 95%: 61-75), in 
the central region, with one study was 55% (CI 95%: 
50-68) and in Tehran was 33% (CI 95%: 25-41). 
The pooled rate one year survival rate according to 
result of Meta-analysis was 47% (CI 95%: 34-61) 
(graph 1). Graph 2 shows the overall rate of five 
year survival according to Meta-analysis was 12% 
(CI 95%: 8-16). 
 
 
 
Chart 1. The Flowchart Stages of Entering the 
Articles into Meta-Analysis. 
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Discussion 
In recent decades some success has been 
obtained in the management and cure of esophageal 
carcinoma. Nevertheless, esophageal carcinoma is 
still a malignant tumor with the poor prognosis [9]. 
Esophageal tumors are considered an endemic 
disease in Iran particularly in the brinks of the 
Caspian Sea [10]. In our study the five year survival 
rate is equal to 12%. In a study carried out in 2008 
by Agrawal et al, the survival rate in patients during 
the first five years after diagnosis is reported 13% 
[11] that conforms to results of our study. In a study 
by Bashash et al. 2011, which tries to compare the 
survival rate for stomach and esophageal cancers in 
Ardebil in Iran and British Colombia in Canada, the 
one year survival rate was estimated 17% in Ardebil 
and 33% in British Colombia [12]. This significant 
difference shows a geographic variation in survival 
rate of esophageal cancer in different parts of the 
world perhaps due to differences in health and 
wellness of people in different areas. Also in this 
study the mortality of esophageal cancer was more 
than the fatality of stomach cancer [12]. In 
Netherlands the five year survival rate for men and 
women was 12.8 % and 9.8 %, respectively [13]. 
This study conforms to results of our study which 
shows the five year survival rate was 12%. In Japan 
2012, by Tamura et al the five year survival rate of 
esophageal cancer was estimated 42.9% and in  
 
Table 1.  The Characteristics of the Studies Entered into the Meta-Analysis 
Study 
region 
Year Sample 
size 
Survival rate 
1 year 2 year 3 year 4 year 5 year 
mashad 2000 190 0.68 0.49 0.36 - - 
Rasht 2008 71 - - - - - 
Rasht 1991 192 0.8 0.61 0.52 0.38 - 
Fars 2001 161 - - - - - 
Ardebil 2000 141 0.26 0.11 0.05 0.02 - 
Babolsar 1992 230 0.42 0.21 0.11 - 0.08 
Isfahan 2001 161 0.58 0.33 0.18 0.15 0.01 
Tehran 1989 245 - 0.08 - - 0.15 
Babol 1900 359 0.24 0.16 - - - 
Golestan 2003 115 0.26 - - - - 
Tahran 2007 100 - - - - - 
Sari 1992 79 - - 0.11 - - 
Golestan 2005 39 - - - - - 
Babol 1993 133 0.48 - - - - 
Tehran 1995 150 0.33 - 0.1 - 0.04 
Rasht 1993 162 0.8 0.5 0.4 0.3 0.2 
Babol 2001 364 0.35 0.15 - - 0.09 
Isfahan 2010 40 - - - - - 
NOTE: Weights are from random effects analysis
.
.
.
.
Overall  (I-squared = 97.9%, p = 0.000)
Tehran(1995)
Rasht(1991)
Ardabil(2000)
Golstan(2003)
2
Mashad(2000)
Subtotal  (I-squared = 98.3%, p = 0.000)
Babol(1993)
3
Rasht(1993)
Babol(1990)
Subtotal  (I-squared = .%, p = .)
4
Bablsar(1992)
Subtotal  (I-squared = .%, p = .)
Babol(2001)
Esfahan(2001)
city(year)
Subtotal  (I-squared = .%, p = .)
1
0.47 (0.34, 0.61)
0.33 (0.25, 0.41)
0.80 (0.74, 0.86)
0.26 (0.19, 0.33)
0.26 (0.18, 0.34)
0.68 (0.61, 0.75)
0.45 (0.28, 0.62)
0.48 (0.40, 0.56)
0.80 (0.74, 0.86)
0.24 (0.20, 0.28)
0.58 (0.50, 0.66)
0.42 (0.36, 0.48)
0.33 (0.25, 0.41)
0.35 (0.30, 0.40)
0.58 (0.50, 0.66)
ES (95% CI)
0.68 (0.61, 0.75)
100.00
9.04
9.15
9.06
9.00
9.10
72.83
8.97
9.13
9.21
9.03
9.11
9.04
9.19
9.03
Weight
9.10
%
  
0-.862 .862
Graph 1. One Year Survival Estimation in the 
Studied Articles Separated by Region (Each 
Line Shows 95% Confidence Interval. The 
Diamond Shape is the Total Survival and 
Confidence Interval). 
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similar article in USA 2012 [14] Blackmon et al. 
was reported 30% [15]. Thus our result is 
considerably lower than developed countries such as 
Japan and the USA.  
Some limitations can be addressed in current 
study. First, most of the final enrolled studies owned 
from inner databases. Second some articles did not 
give the survival rate by year and just report the 
five-year survival rate. 
Of the 18 final articles, 11 were performed in 
the northern reigns of the country including 
Golestan, Mazandaran, as well as Gilan and Ardebil 
provinces. The reason for this can be attributed to 
highest rate of esophageal cancer in northern reigns 
in Iran. In other regions number of the studies 
related to survival in patient with esophageal cancer 
is scarce. So the survival rate in other regions of Iran 
is not clear due to the lack of sufficient data and due 
to the scarcity of studies, the reported estimations 
don't have sufficient accuracy. 
 
Conclusion 
According to results of this study the one year 
survival rate (47%) of esophageal cancer in Iran is 
almost five times more than the five year survival 
rate (12%). Hence, the early diagnosis of the disease 
is very important in order to prolong the survival of 
the patients. 
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